These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Bostick B; Ghosh A; Yue Y; Long C; Duan D Gene Ther; 2007 Nov; 14(22):1605-9. PubMed ID: 17898796 [TBL] [Abstract][Full Text] [Related]
7. Combination of adeno-associated virus and adenovirus vectors expressing bone morphogenetic protein-2 produces enhanced osteogenic activity in immunocompetent rats. Chen Y; Luk KD; Cheung KM; Lu WW; An XM; Ng SS; Lin MC; Kung HF Biochem Biophys Res Commun; 2004 May; 317(3):675-81. PubMed ID: 15081393 [TBL] [Abstract][Full Text] [Related]
8. Construction and analysis of compact muscle-specific promoters for AAV vectors. Wang B; Li J; Fu FH; Chen C; Zhu X; Zhou L; Jiang X; Xiao X Gene Ther; 2008 Nov; 15(22):1489-99. PubMed ID: 18563184 [TBL] [Abstract][Full Text] [Related]
9. AAV vectors for hemophilia B gene therapy. Chao H; Walsh CE Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431 [TBL] [Abstract][Full Text] [Related]
10. Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system. Chahal PS; Aucoin MG; Kamen A J Virol Methods; 2007 Jan; 139(1):61-70. PubMed ID: 17055590 [TBL] [Abstract][Full Text] [Related]
12. Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Huttner NA; Girod A; Perabo L; Edbauer D; Kleinschmidt JA; Büning H; Hallek M Gene Ther; 2003 Dec; 10(26):2139-47. PubMed ID: 14625569 [TBL] [Abstract][Full Text] [Related]
13. Identification of mouse AAV capsid-specific CD8+ T cell epitopes. Sabatino DE; Mingozzi F; Hui DJ; Chen H; Colosi P; Ertl HC; High KA Mol Ther; 2005 Dec; 12(6):1023-33. PubMed ID: 16263332 [TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus DNA in human gestational trophoblastic disease. Kiehl K; Schlehofer JR; Schultz R; Zugaib M; Armbruster-Moraes E Placenta; 2002 May; 23(5):410-5. PubMed ID: 12061857 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the interaction between adeno-associated virus and heparan sulfate using atomic force microscopy. Negishi A; Chen J; McCarty DM; Samulski RJ; Liu J; Superfine R Glycobiology; 2004 Nov; 14(11):969-77. PubMed ID: 15215232 [TBL] [Abstract][Full Text] [Related]
16. Scaling-up production of recombinant AAV vectors for clinical applications. Qu G; McClelland A; Wright JF Curr Opin Drug Discov Devel; 2000 Nov; 3(6):750-5. PubMed ID: 19649903 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of caprine adeno-associated virus (AAV-Go.1) reveals striking similarity to human AAV5. Qiu J; Cheng F; Pintel D Virology; 2006 Dec 5-20; 356(1-2):208-16. PubMed ID: 16926042 [TBL] [Abstract][Full Text] [Related]
19. Gene transfer into skeletal muscle using novel AAV serotypes. Louboutin JP; Wang L; Wilson JM J Gene Med; 2005 Apr; 7(4):442-51. PubMed ID: 15517544 [TBL] [Abstract][Full Text] [Related]